Discovery of Potent and Selective MRCK Inhibitors with Therapeutic Effect on Skin Cancer-Reference-Cited by-同舟云学术

Discovery of Potent and Selective MRCK Inhibitors with Therapeutic Effect on Skin Cancer

Published:2018-01-30 Issue:8 Volume:78 Page:2096-2114
ISSN:0008-5472
Container-title:Cancer Research
language:en
Short-container-title:Cancer Res

Author:

Unbekandt Mathieu,Belshaw Simone,Bower Justin,Clarke Maeve,Cordes Jacqueline,Crighton Diane,Croft Daniel R.,Drysdale Martin J.,Garnett Mathew J.,Gill Kathryn,Gray Christopher,Greenhalgh David A.,Hall James A.M.,Konczal Jennifer,Lilla Sergio,McArthur Duncan,McConnell Patricia,McDonald Laura,McGarry Lynn,McKinnon Heather,McMenemy Carol,Mezna Mokdad,Morrice Nicolas A.,Munro June,Naylor Gregory,Rath Nicola,Schüttelkopf Alexander W.,Sime Mairi,Olson Michael F.

Funder

Cancer Research UK

Medical Research Council

Worldwide Cancer Research

CRUKSU2CWellcome TrustSU2CWellcome Trust

Publisher

American Association for Cancer Research (AACR)

Subject

Cancer Research,Oncology

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tumor-intrinsic CDC42BPB confers resistance to anti-PD-1 immune checkpoint blockade in breast cancer;Molecular Therapy;2024-07

2. Identification of an FMNL2 Interactome by Quantitative Mass Spectrometry;International Journal of Molecular Sciences;2024-05-23

3. MRCK as a Potential Target for Claudin-Low Subtype of Breast Cancer;International Journal of Biological Sciences;2024

4. MRCK activates mouse oocyte myosin II for spindle rotation and male pronucleus centration;Journal of Cell Biology;2023-08-31

5. MRCKα/β positively regulates Gli protein activity;Cellular Signalling;2023-07